Human Genetics

, Volume 97, Issue 2, pp 263–264 | Cite as

Population study of the G1691A mutation (R506% FV Leiden) in the human factor V gene that is associated with resistance to activated protein C

  • A. Braun
  • B. Müller
  • A. A. Rosche
DNA Variants


The mutation G1691A (R506Q) in the human factor V gene is associated with the resistance to activated protein C (APC) that represents a major risk of development of venous thrombosis. A population study of 180 unrelated individuals from south Germany was performed. Examination of the allelic frequencies revealed a high prevalence of this disease-related mutation (Q506, FV Leiden). The heterozygosity rate was 7.8% with a confidence interval between 4% and 11%.


Confidence Interval Internal Medicine Allelic Frequency Metabolic Disease Venous Thrombosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Bettina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64–67Google Scholar
  2. Dahlbdck B (1994) Physiological anticoagulation — resistance to activated protein C and venous thromboembolism. J Clin Invest 94:923–927Google Scholar
  3. Griffin JH, Evatt B, Wideman C, Fernandez JA (1993) Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 82:1989–1993Google Scholar
  4. Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM (1993) Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet 342:1503–1506Google Scholar
  5. Müller B, Clerget-Darpoux F (1991) A test based on the exact probability distribution of the chi-square statistic-incorporation into the MASC method. Ann Hum Genet 55:69–75Google Scholar
  6. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP (1995) Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 332:912–917Google Scholar
  7. Svensson PJ, Dahlbäck B (1994) Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 330:517–522Google Scholar
  8. Zöllner B, Svensson PJ, He X, Dahlbdck B (1994) Identification of the same factor V gene mutation in 47 out of 50 thrombosisprone families with inherited resistance to activated protein C. J Clin Invest 94:2521–2524Google Scholar

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • A. Braun
    • 1
  • B. Müller
    • 2
  • A. A. Rosche
    • 1
  1. 1.Dr. v. Haunersches Kinderspital, Department of Clinical Chemistry and BiochemistryUniversity of MunichGermany
  2. 2.Kinderpoliklinik, Department of Pediatric GeneticsUniversity of MunichGermany

Personalised recommendations